期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Application of Harness Template in Assembly of Complete Machine
1
作者 HE Yunhao GUO Jia FU Ling 《外文科技期刊数据库(文摘版)工程技术》 2021年第9期785-788,共6页
Technological progress is accompanied by the rapid development of electronic products. As an important part of electronic products, electronic machines are gradually diversified and complicated in structure. In order ... Technological progress is accompanied by the rapid development of electronic products. As an important part of electronic products, electronic machines are gradually diversified and complicated in structure. In order to seize the opportunity in the increasingly fierce market competition, it is particularly important to shorten the product design and production cycle while ensuring the product quality. The internal wiring of the whole electronic machine adopts the wiring harness mode for production and assembly, so as to realize the template wiring, and greatly improve the wiring efficiency and product quality. This paper introduces the design and processing method of template for making wire harness, introduces the importance of the development of electronic assembly technology, and discusses the development trend in the future. 展开更多
关键词 harness template WIRING electronic assembly
原文传递
D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma
2
作者 Silvia Pedretti Francesca Palermo +14 位作者 Miriana Braghin Gabriele Imperato Pasquale Tomaiuolo Meral Celikag Marta Boccazzi Veronica Vallelonga Lorenzo Da Dalt Giuseppe Danilo Norata Giorgia Marisi Ilario Giovanni Rapposelli Andrea Casadei-Gardini Serena Ghisletti Maurizio Crestani Emma De Fabiani Nico Mitro 《Signal Transduction and Targeted Therapy》 2025年第7期3990-4009,共20页
Sorafenib,a multi-kinase inhibitor for advanced hepatocellular carcinoma(HCC),often encounters resistance within months of treatment,limiting its long-term efficacy.Despite extensive efforts,reliable plasma biomarkers... Sorafenib,a multi-kinase inhibitor for advanced hepatocellular carcinoma(HCC),often encounters resistance within months of treatment,limiting its long-term efficacy.Despite extensive efforts,reliable plasma biomarkers to monitor drug activity remain elusive.Here,we demonstrate that metabolic reprogramming is a strategic response implemented by cancer cells to survive the therapeutic pressure.Sorafenib suppresses oxidative phosphorylation by disrupting electron transport chain supercomplex assembly and enhancing glycolysis.To mitigate the accumulation of harmful glycolytic byproducts such as advanced glycation endproducts(AGEs),sorafenib-treated cells reroute excess dihydroxyacetone phosphate(DHAP)toward glycerol-3-phosphate(G3P)synthesis,supporting glycerolipid metabolism,NAD^(+)regeneration,and redox balance,rather than producing D-lactate via the glyoxalase pathway.Alongside,resistant cells enhance serine metabolism to boost glutathione synthesis,reinforcing antioxidant defenses.Additionally,sorafenib increases reliance on exogenous non-esterified free fatty acids and triglycerides for phospholipid remodeling.The combined effects of glycerolipid remodeling and enhanced antioxidant capacity facilitate ferroptosis escape,diminishing sorafenib’s activity.Leveraging these metabolic insights,we validate our findings by investigating plasma metabolites alteration in HCC patients.We identify D-lactate accumulation as a predictor of treatment response and glycerol accumulation as a marker of resistance,highlighting their potential as novel biomarkers for sorafenib activity.As sorafenib is used in advanced HCC,early detection of treatment response is critical to guiding the therapeutic decision,optimizing treatment strategies,and improving patient outcomes. 展开更多
关键词 electron transport chain supercomplex assembly hepatocellular carcinoma plasma biomarkers SORAFENIB monitor drug activity advanced hepatocellular carcinoma hcc often metabolic reprogramming oxidative phosphorylation
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部